Reported Earnings • Jun 03
Full year 2026 earnings released: EPS: ₹6.05 (vs ₹1.91 in FY 2025) Full year 2026 results: EPS: ₹6.05 (up from ₹1.91 in FY 2025). Revenue: ₹24.9b (up 24% from FY 2025). Net income: ₹820.3m (up 217% from FY 2025). Profit margin: 3.3% (up from 1.3% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. 공시 • Jun 01
The Andhra Sugars Limited, Annual General Meeting, Sep 24, 2026 The Andhra Sugars Limited, Annual General Meeting, Sep 24, 2026. Buy Or Sell Opportunity • Jun 01
Now 21% undervalued Over the last 90 days, the stock has risen 9.0% to ₹79.91. The fair value is estimated to be ₹102, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 54%. 공시 • May 15
The Andhra Sugars Limited to Report Q4, 2026 Results on May 30, 2026 The Andhra Sugars Limited announced that they will report Q4, 2026 results on May 30, 2026 Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹86.02, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years. New Risk • Mar 19
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹9.30b (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 28% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹9.30b market cap, or US$99.8m). Reported Earnings • Feb 07
Third quarter 2026 earnings released: EPS: ₹1.59 (vs ₹0.06 in 3Q 2025) Third quarter 2026 results: EPS: ₹1.59 (up from ₹0.06 in 3Q 2025). Revenue: ₹6.36b (up 25% from 3Q 2025). Net income: ₹215.2m (up ₹207.4m from 3Q 2025). Profit margin: 3.4% (up from 0.2% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. New Risk • Jan 21
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹9.09b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹9.09b market cap, or US$99.2m). 공시 • Jan 20
The Andhra Sugars Limited to Report Q3, 2026 Results on Feb 05, 2026 The Andhra Sugars Limited announced that they will report Q3, 2026 results on Feb 05, 2026 Board Change • Sep 27
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Challa Chowdary was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Sep 12
Upcoming dividend of ₹0.80 per share Eligible shareholders must have bought the stock before 19 September 2025. Payment date: 29 September 2025. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Reported Earnings • Aug 15
First quarter 2026 earnings released: EPS: ₹1.73 (vs ₹1.09 in 1Q 2025) First quarter 2026 results: EPS: ₹1.73 (up from ₹1.09 in 1Q 2025). Revenue: ₹6.08b (up 27% from 1Q 2025). Net income: ₹234.6m (up 59% from 1Q 2025). Profit margin: 3.9% (up from 3.1% in 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance. Declared Dividend • May 31
Dividend reduced to ₹0.80 Dividend of ₹0.80 is 20% lower than last year. Ex-date: 19th September 2025 Payment date: 29th September 2025 Dividend yield will be 1.1%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (18% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 80% to shift the payout ratio to a potentially unsustainable range, which is more than the 25% EPS decline seen over the last 5 years. 공시 • May 30
The Andhra Sugars Limited announces Annual dividend, payable on September 29, 2025 The Andhra Sugars Limited announced Annual dividend of INR 0.8000 per share payable on September 29, 2025, ex-date on September 19, 2025 and record date on September 19, 2025. 공시 • May 29
The Andhra Sugars Limited, Annual General Meeting, Sep 25, 2025 The Andhra Sugars Limited, Annual General Meeting, Sep 25, 2025. Reported Earnings • Feb 12
Third quarter 2025 earnings released: EPS: ₹0.06 (vs ₹0.74 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.06 (down from ₹0.74 in 3Q 2024). Revenue: ₹5.11b (up 13% from 3Q 2024). Net income: ₹7.82m (down 92% from 3Q 2024). Profit margin: 0.2% (down from 2.2% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 16
Second quarter 2025 earnings released: EPS: ₹0.33 (vs ₹1.38 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.33 (down from ₹1.38 in 2Q 2024). Revenue: ₹5.35b (up 3.3% from 2Q 2024). Net income: ₹44.2m (down 76% from 2Q 2024). Profit margin: 0.8% (down from 3.6% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Declared Dividend • Sep 14
Dividend of ₹2.00 announced Shareholders will receive a dividend of ₹2.00. Ex-date: 17th September 2024 Payment date: 25th October 2023 Dividend yield will be 1.8%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (18% earnings payout ratio) but not covered by cash flows (195% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 80% to shift the payout ratio to a potentially unsustainable range, which is more than the 18% EPS decline seen over the last 5 years. Reported Earnings • Aug 13
First quarter 2025 earnings released: EPS: ₹1.09 (vs ₹1.55 in 1Q 2024) First quarter 2025 results: EPS: ₹1.09 (down from ₹1.55 in 1Q 2024). Revenue: ₹5.02b (up 2.0% from 1Q 2024). Net income: ₹148.0m (down 30% from 1Q 2024). Profit margin: 3.0% (down from 4.3% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹116, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 42% over the past three years. Reported Earnings • Jun 04
Full year 2024 earnings released: EPS: ₹5.54 (vs ₹13.72 in FY 2023) Full year 2024 results: EPS: ₹5.54 (down from ₹13.72 in FY 2023). Revenue: ₹19.3b (down 18% from FY 2023). Net loss: ₹13.2b (down ₹15.0b from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. 공시 • May 31
The Andhra Sugars Limited, Annual General Meeting, Sep 21, 2024 The Andhra Sugars Limited, Annual General Meeting, Sep 21, 2024. Buy Or Sell Opportunity • May 30
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.3% to ₹99.95. The fair value is estimated to be ₹126, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has declined by 7.1%. 공시 • May 24
The Andhra Sugars Limited to Report Q4, 2024 Results on May 30, 2024 The Andhra Sugars Limited announced that they will report Q4, 2024 results on May 30, 2024 Buy Or Sell Opportunity • May 07
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to ₹102. The fair value is estimated to be ₹128, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has declined by 7.1%. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹109, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 91% over the past three years. Buy Or Sell Opportunity • Mar 13
Now 25% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to ₹95.25. The fair value is estimated to be ₹127, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has declined by 7.1%. Reported Earnings • Feb 13
Third quarter 2024 earnings released: EPS: ₹0.74 (vs ₹2.90 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.74 (down from ₹2.90 in 3Q 2023). Revenue: ₹4.60b (down 18% from 3Q 2023). Net income: ₹100.5m (down 75% from 3Q 2023). Profit margin: 2.2% (down from 7.0% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Reported Earnings • Nov 15
Second quarter 2024 earnings released: EPS: ₹1.38 (vs ₹2.88 in 2Q 2023) Second quarter 2024 results: EPS: ₹1.38 (down from ₹2.88 in 2Q 2023). Revenue: ₹5.18b (down 15% from 2Q 2023). Net income: ₹186.9m (down 52% from 2Q 2023). Profit margin: 3.6% (down from 6.4% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • Oct 23
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 1.8%. The fair value is estimated to be ₹144, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 9.2%. Upcoming Dividend • Sep 08
Upcoming dividend of ₹2.00 per share at 1.6% yield Eligible shareholders must have bought the stock before 15 September 2023. Payment date: 25 October 2023. Payout ratio is a comfortable 15% and the cash payout ratio is 80%. Trailing yield: 1.6%. Within top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.8%). Recent Insider Transactions • Aug 26
Executive Director recently bought ₹212k worth of stock On the 23rd of August, Pendyala Sree Ramachandra Venkata Ranga Rao bought around 2k shares on-market at roughly ₹106 per share. This transaction amounted to 4.2% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹312k. Insiders have collectively bought ₹7.8m more in shares than they have sold in the last 12 months. Reported Earnings • Aug 10
First quarter 2024 earnings released: EPS: ₹1.55 (vs ₹5.55 in 1Q 2023) First quarter 2024 results: EPS: ₹1.55 (down from ₹5.55 in 1Q 2023). Revenue: ₹4.99b (down 24% from 1Q 2023). Net income: ₹210.6m (down 72% from 1Q 2023). Profit margin: 4.2% (down from 11% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 19% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Jun 29
Executive Director recently bought ₹232k worth of stock On the 22nd of June, Pendyala Sree Ramachandra Venkata Ranga Rao bought around 2k shares on-market at roughly ₹116 per share. This transaction amounted to 4.3% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹312k. Insiders have collectively bought ₹7.6m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Jun 13
Insider recently bought ₹312k worth of stock On the 6th of June, V. Rajeshwari bought around 3k shares on-market at roughly ₹110 per share. This transaction amounted to 2.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹7.4m more in shares than they have sold in the last 12 months. Reported Earnings • May 30
Full year 2023 earnings released: EPS: ₹13.72 (vs ₹17.87 in FY 2022) Full year 2023 results: EPS: ₹13.72 (down from ₹17.87 in FY 2022). Revenue: ₹24.0b (up 22% from FY 2022). Net income: ₹1.86b (down 23% from FY 2022). Profit margin: 7.8% (down from 12% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. 공시 • May 30
The Andhra Sugars Limited, Annual General Meeting, Sep 25, 2023 The Andhra Sugars Limited, Annual General Meeting, Sep 25, 2023. Agenda: To consider and approve the Dividend for the Year ended 31 March 2023 - INR 2/- (100%) per Equity Share of INR 2/- each. Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹2.90 (vs ₹4.08 in 3Q 2022) Third quarter 2023 results: EPS: ₹2.90 (down from ₹4.08 in 3Q 2022). Revenue: ₹5.66b (up 11% from 3Q 2022). Net income: ₹393.6m (down 29% from 3Q 2022). Profit margin: 7.0% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Dec 27
Insider recently bought ₹993k worth of stock On the 23rd of December, V. Rajeshwari bought around 8k shares on-market at roughly ₹124 per share. This transaction amounted to 6.5% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₹4.1m. Insiders have collectively bought ₹7.1m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Dec 05
Insider recently bought ₹1.0m worth of stock On the 2nd of December, V. Rajeshwari bought around 8k shares on-market at roughly ₹130 per share. This transaction amounted to 7.3% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₹4.1m. Insiders have collectively bought ₹5.2m more in shares than they have sold in the last 12 months. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. No experienced directors. 9 highly experienced directors. Independent Director Parvataneni Rao was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Oct 01
Insider recently bought ₹4.1m worth of stock On the 28th of September, V. Rajeshwari bought around 30k shares on-market at roughly ₹137 per share. This transaction amounted to 38% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Upcoming Dividend • Sep 08
Upcoming dividend of ₹4.00 per share Eligible shareholders must have bought the stock before 15 September 2022. Payment date: 26 October 2022. Payout ratio is a comfortable 10% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.7%). Reported Earnings • Aug 11
First quarter 2023 earnings released: EPS: ₹5.55 (vs ₹3.76 in 1Q 2022) First quarter 2023 results: EPS: ₹5.55 (up from ₹3.76 in 1Q 2022). Revenue: ₹6.63b (up 60% from 1Q 2022). Net income: ₹752.8m (up 48% from 1Q 2022). Profit margin: 11% (in line with 1Q 2022). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹17.87 (vs ₹9.96 in FY 2021) Full year 2022 results: EPS: ₹17.87 (up from ₹9.96 in FY 2021). Revenue: ₹20.0b (up 33% from FY 2021). Net income: ₹2.42b (up 80% from FY 2021). Profit margin: 12% (up from 8.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 8 highly experienced directors. Independent Director P. Rao was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 15
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹4.08 (up from ₹1.85 in 3Q 2021). Revenue: ₹5.09b (up 43% from 3Q 2021). Net income: ₹552.5m (up 120% from 3Q 2021). Profit margin: 11% (up from 7.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jan 25
Investor sentiment improved over the past week After last week's 15% share price gain to ₹152, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 203% over the past three years. Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment improved over the past week After last week's 18% share price gain to ₹694, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 143% over the past three years. Reported Earnings • Nov 15
Second quarter 2022 earnings released: EPS ₹20.81 (vs ₹12.13 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹4.77b (up 22% from 2Q 2021). Net income: ₹564.1m (up 72% from 2Q 2021). Profit margin: 12% (up from 8.4% in 2Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • Aug 15
First quarter 2022 earnings released: EPS ₹18.81 (vs ₹10.28 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹4.14b (up 15% from 1Q 2021). Net income: ₹509.9m (up 83% from 1Q 2021). Profit margin: 12% (up from 7.7% in 1Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • Jul 03
Full year 2021 earnings released: EPS ₹49.79 (vs ₹74.92 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹15.1b (up 2.1% from FY 2020). Net income: ₹1.35b (down 34% from FY 2020). Profit margin: 8.9% (down from 14% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improved over the past week After last week's 15% share price gain to ₹498, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 68% over the past three years. Valuation Update With 7 Day Price Move • Apr 30
Investor sentiment improved over the past week After last week's 17% share price gain to ₹386, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years. Is New 90 Day High Low • Feb 22
New 90-day low: ₹287 The company is down 2.0% from its price of ₹293 on 24 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Feb 17
Third quarter 2021 earnings released: EPS ₹9.26 (vs ₹11.97 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹3.56b (down 4.4% from 3Q 2020). Net income: ₹251.1m (down 23% from 3Q 2020). Profit margin: 7.1% (down from 8.7% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Jan 12
New 90-day high: ₹343 The company is up 19% from its price of ₹289 on 14 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period. Is New 90 Day High Low • Dec 15
New 90-day high: ₹339 The company is up 7.0% from its price of ₹316 on 16 September 2020. The Indian market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Nov 13
Second quarter 2021 earnings released: EPS ₹12.13 The company reported a soft second quarter result with weaker earnings and profit margins, although revenues were improved. Second quarter 2021 results: Revenue: ₹3.95b (up 3.1% from 2Q 2020). Net income: ₹328.9m (down 36% from 2Q 2020). Profit margin: 8.3% (down from 14% in 2Q 2020). The decrease in margin was driven by higher expenses.